Estrogenic activity in white and red wine extracts

Journal of Agricultural and Food Chemistry

Volumn 51, Issue 7, 2003, Pages 1850-1857

  Klinge, Carolyn M ^a   Risinger, Kelly E ^a   Watts, Mary Beth ^a   Beck, Verena ^b   Eder, Reinhard ^c   Jungbauer, Alois ^b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF AGRICULTURAL SCIENCES   (Austria)

^c Institute for Viticulture and Pomology   (Austria)

Author keywords

Estrogen; Estrogen receptor; Phytoestrogen; Resveratrol; Transcription

Indexed keywords

3,5,4' TRIHYDROXYSTILBENE; 4 HYDROXYTAMOXIFEN; ANTHOCYANIN; BETA GALACTOSIDASE; COPPER; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FLAVAN DERIVATIVE; FLAVONOID; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHEMICAL ANALYSIS; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; GRAPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PROTEIN EXPRESSION; REPORTER GENE; TUMOR CELL; WINE; YEAST;

ANIMALS; BETA-GALACTOSIDASE; BREAST NEOPLASMS; CHO CELLS; CRICETINAE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; GENE EXPRESSION; GENES, REPORTER; HUMANS; PLANT EXTRACTS; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; SACCHAROMYCES CEREVISIAE; STILBENES; TAMOXIFEN; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED; VITIS; WINE;

ANIMALIA; MAMMALIA; VITACEAE; VITIS SP.;

EID: 0037467458     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf0259821     Document Type: Article

References (47)

1. Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W.; Fong, H. H. S.; Farnsworth, N. R.; Kinghorn, A. D.; Mehta, R. G.; Moon, R. C.; Pezzuto, J. M. Cancer chemoprevention activity of resveratrol, a natural product derived from grapes. Science 1997, 275, 218-220.
2. Jang, M.; Pezzuto, J. M. Cancer chemopreventive activity of resveratrol. Drugs Exp. Clin. Res. 1999, 25, 65-77.
3. Hsieh, T. C.; Wu, J. M. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp. Cell Res. 1999, 249, 109-115.
4. Ray, P. S.; Maulik, G.; Cordis, G.; Bertelli, A. A.; Bertelli, A.; Das, D. K. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radical Biol. Med. 1999, 27, 160-169.
5. Goldberg, D.; Tsang, E.; Karumanchiri, A.; Diamandis, E.; Soleas, G.; Ng, E. Method to assay the concentrations of phenolic constituents of biological interest in wines. Anal. Chem. 1996, 68, 1688-1694.
6. Bertelli, A.; Bertelli, A. A.; Gozzini, A.; Giovannini, L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp. Clin. Res. 1998, 24, 133-138.
7. Bertelli, A. A.; Giovannini, L.; Stradi, R.; Urien, S.; Tillement, J. P.; Bertelli, A. Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats. Drugs Exp. Clin. Res. 1998, 24, 51-55.
8. Juan, M. E.; Lamuela-Raventos, R. M.; de la Torre-Boronat, M. C.; Planas, J. M. Determination of trans-resveratrol in plasma by HPLC. Anal. Chem. 1999, 71, 747-50.
9. Basly, J. P.; Marre-Fournier, F.; Le Bail, J. C.; Habrioux, G.; Chulia, A. J. Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol. Life Sci. 2000, 66, 769-777.
10. Gehm, B. D.; McAndrews, J. M.; Chien, P. Y.; Jameson, J. L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 14138-14143.
11. Sun, G.; Porter, W.; Safe, S. Estrogen-induced retinoic acid receptor alpha 1 gene expression: role of estrogen receptor-Sp1 complex. Mol. Endocrinol. 1998, 12, 882-890.
12. McKenna, N. J.; Lanz, R. B.; O'Malley, B. W. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 1999, 20, 321-344.
13. Bowers, J. L.; Tyulmenkov, V. V.; Jernigan, S. C.; Klinge, C. M. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 2000, 141, 3657-3667.
14. Jungbauer, A.; Beck, V. Yeast reporter system for rapid determination of estrogenic activity. J. Chromatogr. B 2002, 777, 167-178.
15. Lyttle, C. R.; Damian-Matsumura, P.; Juul, H.; Butt, T. R. Human estrogen receptor regulation in a yeast model system and studies on receptor agonists and antagonists. J. Steroid Biochem. Mol. Biol. 1992, 42, 677-685.
16. Tyulmenkov, V. T.; Jernigan, S. C.; Klinge, C. M. Comparison of transcriptional synergy of estrogen receptors alpha and beta from multiple tandem estrogen response elements. Mol. Cell. Endocrinol. 2000, 165, 151-161.
17. Reese, J. C.; Katzenellenbogen, B. S. Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human estrogen receptor overexpressed in mammalian cells. Nucleic Acids Res. 1991, 19, 6595-6602.
18. Kuiper, G. G.; Enmark, E.; Pelto-Huikko, M.; Nilsson, S.; Gustafsson, J.-A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 5925-5930.
19. Klinge, C. M.; Bowers, J. L.; Kulakosky, P. C.; Kamboj, K. K.; Swanson, H. I. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements. Mol. Cell. Endocrinol. 1999, 157, 105-119.
20. Klinge, C. M. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF). J. Steroid Biochem. Mol. Biol. 1999, 71, 1-19.
21. Klinge, C. M.; Jernigan, S. C.; Smith, S. L.; Tyulmenkov, V. V.; Kulakosky, P. C. Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor α. Mol. Cell. Endocrinol. 2001, 174, 151-166.
22. Rosenberg, Za. R. S.; Jenkins, D. J.; Diamandis, E. P. Steroid hormone activity of flavonoids and related compounds. Breast Cancer Res. Treat. 2000, 62, 35-49.
23. Abu-Amsha, R.; Croft, K. D.; Puddey, I. B.; Proudfoot, J. M.; Beilin, L. J. Phenolic content of various beverages determines the extent of inhibition of human serum and low-density lipoprotein oxidation in vitro: identification and mechanism of action of some cinnamic acid derivatives from red wine. Clin. Sci. (London) 1996, 91, 449-58.
24. McInerney, E. M.; Weis, K. E.; Sun, J.; Mosselman, S.; Katzenellenbogen, B. S. Transcription activation by the human estrogen receptor subtype beta (ER beta) studied with ER beta and ER alpha receptor chimeras. Endocrinology 1998, 139, 4513-4522.
25. Gaido, K.; Dohme, L.; Wang, F.; Chen, I.; Blankvoort, B.; Ramamoorthy, K.; Safe, S. Comparative estrogenic activity of wine extracts and organochlorine pesticide residues in food. Environ. Health Perspect. 1998, 106 (Suppl. 6), 1347-1351.
26. Bhat, K. P.; Pezzuto, J. M. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells. Cancer Res. 2001, 61, 6137-6144.
27. Jones, P. S.; Parrott, E.; White, I. N. Activation of transcription by estrogen receptor alpha and beta is cell type- and promoter-dependent. J. Biol. Chem. 1999, 274, 32008-32014.
28. Shang, Y.; Hu, X.; DiRenzo, J.; Lazar, M. A.; Brown, M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000, 103, 843-852.
29. Shang, Y.; Brown, M. Molecular determinants for the tissue specificity of SERMs. Science 2002, 295, 2465-2468.
30. Klinge, C. M. Estrogen receptor interaction with co-activators and co-repressors. Steroids 2000, 65, 227-251.
31. Brunner, N.; Boysen, B.; Jirus, S.; Skaar, T. C.; Holst-Hansen, C.; Lippman, J.; Frandsen, T.; Spang-Thomsen, M.; Fuqua, S. A.; Clarke, R. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross -resistance to the nonsteroidal antiestrogen tamoxifen. Cancer Res. 1997, 57, 3486-3493.
32. Su, J. L.; McKee, D. D.; Ellis, B.; Kadwell, S. H.; Wisely, G. B.; Moore, L. B.; Triantafillou, J. A.; Kost, T. A.; Fuqua, S.; Moore, J. T. Production and characterization of an estrogen receptor beta subtype-specific mouse monoclonal antibody. Hybridoma 2000, 19, 481-487.
33. Mgbonyebi, O. P.; Russo, J.; Russo, I. H. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int. J. Oncol. 1998, 12, 865-869.
34. Lu, R.; Serrero, G. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J. Cell Physiol. 1999, 179, 297-304.
35. Ashby, J.; Tinwell, H.; Pennie, W.; Brooks, A. N.; Lefevre, P. A.; Beresford, N.; Sumpter, J. P. Partial and weak oestrogenicity of the red wine constituent resveratrol: consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects. J. Appl. Toxicol. 1999, 19, 39-45.
36. Nakagawa, H.; Kiyozuka, Y.; Uemura, Y.; Senzaki, H.; Shikata, N.; Hioki, K.; Tsubura, A. Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. J. Cancer Res. Clin. Oncol. 2001, 127, 258-64.
37. Damianaki, A.; Bakogeorgou, E.; Kampa, M.; Notas, G.; Hatzoglou, A.; Panagiotou, S.; Gemetzi, C.; Kouroumalis, E.; Martin, P. M.; Castanas, E. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J. Cell Biochem. 2000, 78, 429-441.
38. Bhat, K. P.; Lantvit, D.; Christov, K.; Mehta, R. G.; Moon, R. C.; Pezzuto, J. M. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res. 2001, 61, 7456-7463.
39. Bagchi, D.; Das, D. K.; Tosaki, A.; Bagchi, M.; Kothari, S. C. Benefits of resveratrol in women's health. Drugs Exp. Clin. Res. 2001, 27, 233-248.
40. German, J. B.; Walzem, R. L. The health benefits of wine. Annu. Rev. Nutr. 2000, 20, 561-593.
41. Das, D. K.; Sato, M.; Ray, P. S.; Maulik, G.; Engelman, R. M.; Bertelli, A. A.; Bertelli, A. Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp. Clin. Res. 1999, 25, 115-120.
42. Ruf, J. C. Wine and polyphenols related to platelet aggregation and atherothrombosis. Drugs Exp. Clin. Res. 1999, 25, 125-31.
43. Mortensen, E. L.; Jensen, H. H.; Sanders, S. A.; Reinisch, J. M. Better psychological functioning and higher social status may largely explain the apparent health benefits of wine: a study of wine and beer drinking in young Danish adults. Arch. Intern. Med. 2001, 161, 1844-1848.
44. Kuiper, G. G.; Carlsson, B.; Grandien, J.; Enmark, E.; Haggblad, J.; Nilsson, S.; Gustafsson, J.-A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997, 138, 863-870.
45. Celotti, E.; Ferrarini, R.; Zironi, R.; Conte, L. S. Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone. J. Chromatogr. 1996, 730, 47-52.
46. Bruggisser, R.; von Daeniken, K.; Jundt, G.; Schaffner, W.; Tullberg-Reinert, H. Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay. Planta Med. 2002, 68 (5), 445-448.
47. Mazur, W. Phytoestrogen content in foods. Baillieres Clin. Endocrinol. Metab. 1998, 12 (4), 729-742.